Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception

Patients with sickle cell disease (SCD) are at a risk of thromboembolism (TE), and use of hormonal contraception can further increase that risk. This study aims to assess patterns of hormonal contraceptive use and compare risk of contraception-related TE between combined hormonal contraceptives (CHC...

Descripción completa

Detalles Bibliográficos
Autores principales: Bala, Natasha S., Stanek, Joseph R., Vesely, Sara K., Cronin, Robert M., Creary, Susan E., Roe, Andrea H., Xu, Wendy, O’Brien, Sarah H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582388/
https://www.ncbi.nlm.nih.gov/pubmed/37585480
http://dx.doi.org/10.1182/bloodadvances.2023010204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582388/
https://www.ncbi.nlm.nih.gov/pubmed/37585480
http://dx.doi.org/10.1182/bloodadvances.2023010204

Ejemplares similares